Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 10/2012

01-10-2012 | Healing Arts: Materia Medica

Brave Silence

Author: Joshua Liao, BA, BS

Published in: Journal of General Internal Medicine | Issue 10/2012

Login to get access

Excerpt

Susan’s eyes searched the floor, her gaze fleeing mine. Finally she lifted it towards the ceiling, to roll tears back, and let out a quick laugh.
“You must think I’m stupid.”
…
Metadata
Title
Brave Silence
Author
Joshua Liao, BA, BS
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 10/2012
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-012-2032-6

Other articles of this Issue 10/2012

Journal of General Internal Medicine 10/2012 Go to the issue

Original Research

Access to and Use of $4 Generic Programs in Medicare

Original Research

A Randomized Trial of Peer Coach and Office Staff Support to Reduce Coronary Heart Disease Risk in African-Americans with Uncontrolled Hypertension

Clinical Practice: Clinical Vignettes

Buyers Beware: Lead Poisoning due to Ayurvedic Medicine

Original Research

End-of-Life Care from the Perspective of Primary Care Providers

Original Research

Literacy, Cognitive Function, and Health: Results of the LitCog Study

Erratum

Erratum to: Effect of Patient- and Medication-Related Factors on Inpatient Medication Reconciliation Errors
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits